09/06/2026
Researchers have developed an ultra-low-cost blood test that may help detect certain cancers at an early stage. The test focuses on a protein called ORF1p, which is produced when normally silent “jumping genes” become active in cancer cells.
Using highly sensitive detection methods combined with nanobody technology, the test can identify trace levels of ORF1p in blood samples. Early studies have shown its presence in patients with cancers such as ovarian, colon, and esophageal cancer, while remaining undetected in healthy individuals.
Beyond early detection, the approach may also help monitor treatment response, as ORF1p levels appear to decrease after successful therapy. While it cannot yet identify the exact location or detect all cancer types, it represents a promising step forward in early screening for conditions such as Cancer.
Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment.